Secondary acute myeloid leukemia - a single center experience

Neoplasma

Volumn 57, Issue 2, 2010, Pages 170-178

  Szotkowski, T ^a   Rohon, P ^a   Zapletalova, J ^a   Sicova, K ^a   Hubacek, J ^a   Indrak, K ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Chemotherapy; Myelodysplastic syndrome; Prognosis; Secondary leukemia; Stem cell transplantation

Indexed keywords

ARABINOSIDE; CYTOSINE; ETOPOSIDE; FLUDARABINE; MITOXANTRONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CYTOGENETICS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PROGNOSIS; SECONDARY ACUTE GRANULOCYTIC LEUKEMIA; CHRONIC DISEASE; CLINICAL TRIAL; MIDDLE AGED; MYELOPROLIFERATIVE DISORDER; REMISSION; RETROSPECTIVE STUDY; SECOND CANCER; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; CHRONIC DISEASE; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77953624151     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2010_02_170     Document Type: Article

References (16)

1. LARSON RA: Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia? Best Practice & Research Clinical Haematology 2007; Vol 20 (1): 29-37. doi:10.1016/j.beha.2006.10.006
2. LARSON RA: Etiology and Management of Therapy-Related Myeloid Leukemia. Hematology 2007, American Society of Hematology, pp. 453-459.
3. LEONE G, PAGANO L, BEN-YEHUDA D, VOSO MT. Therapy-related leukemia and myelodysplasia: susceptibility and incidence. Haematologica 2007; 92: 1389-1398. doi:10.3324/haematol.11034
4. HARRIS NL, JAFFE ES, DIEBOLD J, FLANDRIN G, MULLER-HERMELINK HK, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999, 17: 3835-3849.
5. BAGBY GC, MEYERS G. Bone Marrow Failure as a Risk Factor for Clonal Evolution: Prospects for Leukemia Prevention. Hematology 2007, American Society of Hematology, pp. 40-46.
6. GAJEWSKI JL, HO WG, NIMER SD, HIRJI KF, GEKELMAN L, et al. Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome. J Clin Oncol 1989; 7: 1637-1645.
7. NEUGUT AI, ROBINSON E, NIEVES J, MURRAY T, TSAI WY. Poor survival of treatment-related acute nonlymphocytic leukemia. JAMA 1990; 264: 1006-1008. doi:10.1001/jama.264.8.1006
8. KANTARJIAN HM, KEATING MJ. Therapy-related leukemia and myelodysplastic syndrome. Semin Oncol 1987; 14: 435-443.
9. KAPLAN EL, MEIER P. Nonparametric estimation from incomplete observations. J Am Stat Ass, 53, 1958, p.457-481. doi:10.2307/2281868
10. MANN H, WHITNEY D. On a test of whether one of two variables is stochastically larger than the other. Annals of Mathematical Statistics, 18, 1947, p. 50-60. doi:10.1214/ aoms/1177730491
11. FISHER RA. Statistical Methods for Research Workers. Edinburgh: Oliver and Boyd 1938
12. SCHOCH C, SCHNITTTGER S, KLAUS M, KERN W, HIDDEMANN W, HAFERLACH T. AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Blood 2003, 102 (7): 2395-2402. doi:10.1182/blood-2003-02-0434
13. LEONE G, MELE L, PULSONI A, EQUITANI F, PAGANO L. The incidence of secondary leukemias. Haematologica 1999; 84 (10): 937-945.
14. MARBELLO L, RICCI F, NOSARI AM, TURRINI M, NADOR G, et al. Outcome of hyperleukocytic adult acute myeloid leukaemia: A single-center retrospective study and review of literature. Leukemia Research 2008; 32 (8): 1221-1227. doi:10.1016/j.leukres.2008.01.004
15. BEAUMONT M, SANZ M, CARLI PM. Therapy-Related Acute Promyelocytic Leukemia. J Clin Oncol 2003; 21: 2123-2137. doi:10.1200/JCO.2003.09.072
16. RAO A, HILLS RK, STILLER C, GIBSON BE, DE GRAAF SS, et al. Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials